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Abstract
Enterotoxigenic F4-fimbriated Escherichia coli is associated with diarrheal disease in neonatal and postweaning pigs. The F4
fimbriae mediate attachment of the bacteria to the pig intestinal epithelium, enabling an efficient delivery of diarrhea-
inducing enterotoxins to the target epithelial cells. There are three variants of F4 fimbriae designated F4ab, F4ac and F4ad,
respectively, having different antigenic and adhesive properties. In the present study, the binding of isolated F4ab, F4ac and
F4ad fimbriae, and F4ab/ac/ad-fimbriated E. coli, to glycosphingolipids from erythrocytes and from porcine small intestinal
epithelium was examined, in order to get a comprehensive view of the F4-binding glycosphingolipids involved in F4-
mediated hemagglutination and adhesion to the epithelial cells of porcine intestine. Specific interactions between the F4ab,
F4ac and F4ad fimbriae and both acid and non-acid glycosphingolipids were obtained, and after isolation of binding-active
glycosphingolipids and characterization by mass spectrometry and proton NMR, distinct carbohydrate binding patterns
were defined for each fimbrial subtype. Two novel glycosphingolipids were isolated from chicken erythrocytes, and
characterized as GalNAca3GalNAcß3Galß4Glcß1Cer and GalNAca3GalNAcß3Galß4GlcNAcß3Galß4Glcß1Cer. These two
compounds, and lactosylceramide (Galß4Glcß1Cer) with phytosphingosine and hydroxy fatty acid, were recognized by all
three variants of F4 fimbriae. No binding of the F4ad fimbriae or F4ad-fimbriated E. coli to the porcine intestinal
glycosphingolipids occurred. However, for F4ab and F4ac two distinct binding patterns were observed. The F4ac fimbriae
and the F4ac-expressing E. coli selectively bound to galactosylceramide (Galß1Cer) with sphingosine and hydroxy 24:0 fatty
acid, while the porcine intestinal glycosphingolipids recognized by F4ab fimbriae and the F4ab-fimbriated bacteria were
characterized as galactosylceramide, sulfatide (SO3-3Galß1Cer), sulf-lactosylceramide (SO3-3Galß4Glcß1Cer), and globo-
triaosylceramide (Gala4Galß4Glcß1Cer) with phytosphingosine and hydroxy 24:0 fatty acid. Finally, the F4ad fimbriae
and the F4ad-fimbriated E. coli, but not the F4ab or F4ac subtypes, bound to reference gangliotriaosylceramide
(GalNAcß4Galß4Glcß1Cer), gangliotetraosylceramide (Galß3GalNAcß4Galß4Glcß1Cer), isoglobotriaosylceramide (Gala3-
Galß4Glcß1Cer), and neolactotetraosylceramide (Galß4GlcNAcß3Galß4Glcß1Cer).
Citation: Coddens A, Valis E, Benktander J, A˚ngstro¨m J, Breimer ME, et al. (2011) Erythrocyte and Porcine Intestinal Glycosphingolipids Recognized by F4 Fimbriae
of Enterotoxigenic Escherichia coli. PLoS ONE 6(9): e23309. doi:10.1371/journal.pone.0023309
Editor: Ulrich Dobrindt, Universita¨t Mu¨nster, Germany
Received April 28, 2011; Accepted July 15, 2011; Published September 16, 2011
Copyright:  2011 Coddens et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by the Swedish Research Council/Medicine (S.T., Grant no. 12628), the Swedish Cancer Foundation (S.T.), and the Fonds voor
Wetenschappelijk Onderzoek Vlaanderen (FWO-Vlaanderen (Grant no. G.0389.07 and Grant no. G.0263.07)). A.C. is supported by the agency for Innovation by
Science and Technology (IWT), and E.V. was supported by the Mucosal Immunobiology and Vaccine Center/Swedish Foundation for Strategic Research. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Susann.Teneberg@medkem.gu.se
Introduction
Adhesion of microbes and microbial toxins to their target tissue
by binding to cell surface carbohydrates is nowadays textbook
knowledge, as e.g. the binding of influenza virus to sialic acid-
containing glycoconjugates, cholera toxin to the GM1 ganglioside,
and uropathogenic P-fimbriated Escherichia coli to Gala4Gal-
containing glycosphingolipids. However, for many microbial
adhesins the target cell receptors have not yet been identified.
Enterotoxigenic E. coli (ETEC) infections are a major cause of
diarrhea in young pigs. Infecting bacteria adhere to and colonize the
intestinal epithelium and cause diarrhea primarily by the produc-
tion of heat-labile and/or heat-stable enterotoxin (LT and ST
respectively). Adherence is mediated by fimbrial structures, and
porcine ETEC primarily express five types of fimbriae designated
F4 (K88), F5 (K99), F6 (987P), F41 and F18. F4 fimbriae are the
most prevalent fimbrial structures expressed by porcine ETEC
causing diarrhea and mortality in newborn, suckling and newly
weaned piglets [1]. The F4 fimbriae are composed of a large
number of the major subunit FaeG, with a small number of minor
subunits interspersed throughout the structure [2]. F4 fimbriae are
expressed by the fae-operon, coding for the regulatory proteins FaeA
and FaeB [3], the fimbrial tip protein FaeC [4], the usher FaeD [5],
the chaperone FaeE [6], the minor fimbrial shaft subunits FaeF and
FaeH [7], the adhesive major subunit FaeG [8], and the minor
subunits FaeI and FaeJ with undefined roles.
There are three antigenically distinct variants of F4 fimbriae
designated F4ab, F4ac and F4ad, respectively, distinguished by
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amino acid substitutions in the FaeG subunit [2,9,10]. Studies on
the interactions of the variants of F4 fimbriae with erythrocytes,
intestinal mucus and intestinal epithelial cells have demonstrated
that the F4ab, F4ac and F4ad fimbriae have different, but related,
carbohydrate binding specificities (reviewed in [2]), and several
receptor candidates for each variant have been suggested. Studies
of the hemagglutinating properties of F4ab-, F4ac- and F4ad-
expressing E. coli, using a panel of erythrocytes from different
species, showed that rabbit and guinea pig erythrocytes were
agglutinated in a mannose-resistant manner by all three serotypes
[8]. Pig and rat erythrocytes were agglutinated by F4ab- and
F4ad-fimbriated E. coli, while chicken erythrocytes were selectively
agglutinated by F4ab-fimbriated bacteria.
Previous studies of the carbohydrate recognition of F4ab-(K88ab-)
fimbriated E. coli using reference glycosphingolipids, demonstrated a
binding to galactosylceramide (Galß1Cer) with hydroxy ceramide,
lactosylceramide (Galß4Glcß1Cer), gangliotriaosylceramide (Gal-
NAcß4Galß4Glcß1Cer), and gangliotetraosylceramide (Galß3Gal-
NAcß4Galß4Glcß1Cer), leading to the conclusion that a Galß1 was
necessary for binding to occur [11]. Another glycosphingolipid
binding study demonstrated binding of F4ab-, F4ac- and F4ad-
fimbriae to lactotriaosylceramide (GlcNAcß3Galß4Glcß1Cer), neo-
lactotetraosylceramide (Galß4GlcNAcß3Galß4Glcß1Cer), and neo-
lactohexaosylceramide (Galß4GlcNAcß3Galß4GlcNAcß3Galß4Glc-
ß1Cer), globotriaosylceramide (Gala4Galß4Glcß1Cer), gangliotri-
and gangliotetraosylceramide [12]. By exoglycosidase digestion of
porcine serum transferrin it was also demonstrated that the F4ab
adhesin recognizes GlcNAc residues in the core chain of N-linked
glycans. Taken together, these results lead to the conclusion that the
minimal binding epitope for all three variants of the F4-fimbriae is a ß-
linked HexNAc residue, and that an increased binding is obtained by
substitution of the HexNAc with a terminal Galß. In addition, a
porcine intestinal glycosphingolipid recognized by F4ad, but not by
F4ab or F4ac, has been identified as neolactotetraosylceramide [13].
In order to get a comprehensive view of the F4-binding
glycosphingolipids involved in F4-mediated hemagglutination and
adhesion to the epithelial cells of porcine intestine, the binding of
isolated F4 fimbriae, and F4-fimbriated E. coli, to glycosphingo-
lipids from erythrocytes (human, chicken, guinea pig, rabbit and
porcine) and from porcine small intestinal epithelium was
examined in the present study. Specific interactions between the
F4ab, F4ac and F4ad fimbriae and both acid and non-acid
glycosphingolipids were obtained, and after isolation of binding-
active glycosphingolipids and characterization by mass spectrom-
etry and proton NMR, distinct binding patterns were defined for
each fimbrial subtype.
Results
Characterization of native and mutant F4 fimbriae
Wild type and deletion mutant F4 fimbriae were isolated for
glycosphingolipid binding experiments. When analyzed by SDS-
PAGE the isolated F4 fimbriae variants all migrated as single
bands, which represent the major subunit FaeG, and the apparent
molecular weight of the proteins was in agreement with the
predicted molecular masses (Figure S1) [2].
Binding of F4 fimbriae and F4-fimbriated E. coli to
erythrocyte glycosphingolipids
The initial F4 binding studies were done using mixtures of total
acid and non-acid glycosphingolipids isolated from human,
chicken, guinea pig, rabbit and pig erythrocytes. No binding to
the acid glycosphingolipid fractions was obtained (data not shown).
However, all three fimbriae, and the three corresponding variants
of F4-fimbriated bacteria, selectively bound to three compounds in
the non-acid glycosphingolipid fraction of chicken erythrocytes
(Fig. 1, lane 2). The binding-active compounds migrated in the
mono-, tetra- and hexaglycosylceramide regions, respectively. In
addition, the F4ad fimbriae and the F4ad-fimbriated E.coli
distinctly bound to the major compound of guinea pig erythro-
cytes, migrating in the triglycosylceramide region (Fig. 1D and G,
respectively, lane 3). This compound was not recognized by the
F4ab or F4ac fimbriae or the bacteria expressing F4ab or F4ac
fimbriae. The major glycosphingolipid of guinea pig erythrocytes
is gangliotriaosylceramide (GalNAcß4Galß4Glcß1Cer) [14], and
gangliotriaosylceramide isolated from this source was recognized
by F4ad fimbriae and F4ad-expressing E. coli (see below).
Isolation of the F4 fimbriae binding slow-migrating
glycosphingolipids of chicken erythrocytes
Previously characterized glycosphingolipids of chicken erythro-
cytes are galactosylceramide, lactosylceramide, and the Forssman
pentaglycosylceramide (GalNAca3GalNAcß3Gala4Galß4Glcß1-
Cer) [15]. Here we focused on the F4 binding glycosphingolipids
of chicken erythrocytes migrating in the tetra- and hexaglyco-
sylceramide regions. These F4-binding glycosphingolipids were
isolated by chromatography on an Iatrobeads column, and the
fractions obtained were tested for F4ab and F4ad binding activity
using 125I-labeled fimbriae (exemplified for F4ad in Fig. 2B). After
pooling of binding-active fractions, 0.5 mg of a fraction containing
the binding-active compound migrating in the tetraglycosylcer-
amide region (designated fraction C:tetra-I; Fig. 2, lane 2), and less
than 100 mg of the binding-active hexaglycosylceramide (desig-
nated fraction C:hexa; Fig. 2, lane 5), were obtained. Proton NMR
showed that fraction C:tetra-I was a mixture of four glycosphin-
golipids. This fraction was therefore further separated on an
Iatrobeads column and, after pooling of the F4-binding fractions,
0.2 mg was obtained (designated fraction C:tetra-II).
ESI/MS of fraction C:tetra-II
ESI/MS of the native fraction C:tetra-II gave a series of
pseudomolecular ions [M-H+]2 at m/z 1282–1394, indicating a
tetraglycosylceramide with two HexNAc and two Hex, and with
sphingosine and hydroxy 16:0-24:0 fatty acids (data not shown).
MS2 of the predominant [M-H+]2 ion at m/z 1282 gave a series of
Y and Z ions identifying a glycosphingolipid with HexNAc-
HexNAc-Hex-Hex sequence and with sphingosine and hydroxy
16:0 fatty acid (Figure S2).
Capillary-LC/MS and MS/MS
The oligosaccharides obtained from fraction C:tetra-II by
hydrolysis with Rhodococcus endoglycoceramidase II, were analyzed
by LC-ESI/MS using a graphitized carbon column [16]. The
major saccharide of this fraction was detected as a [M-H]2 ion at
m/z 747, eluting at 21.5–22.4 min (Fig. 3A). MS2 of the [M-H]2
ion at m/z 747 resulted in a series of prominent C-type fragment
ions (C1 at m/z 220, C2 at m/z 423, and C3 at m/z 585) identifying
a tetrasaccharide with HexNAc-HexNAc-Hex-Hex sequence
(Fig. 3B). The 0,2A4 ion at m/z 687 and the
0,2A4-H2O ion at
m/z 669 were obtained by cross-ring cleavages of the 4-substituted
Glc of the internal lactose (Galß4Glc) part. However, no other
cross-ring cleavage ions were observed, suggesting that the two
terminal HexNAcs were 3-linked [16].
The major saccharide derived from fraction C:hexa gave a [M-
H]2 ion at m/z 1112, eluting at 23.0–23.2 min (Fig. 3C). The MS2
spectrum had a series of C-type fragment ions (C2 at m/z 423, C3
at m/z 585, C4 at m/z 787 and C5 at m/z 950) demonstrating a
Glycosphingolipid Recognition by F4 Fimbriae
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hexasaccharide with HexNAc-HexNAc-Hex-HexNAc-Hex-Hex
sequence (Fig. 3D). The prominent cross-ring 0,2A4 fragment ion
at m/z 687, and the accompanying 0,2A4-H2O fragment ion at m/z
669, indicated a 4-substitution of the internal HexNAc, i.e. a type 2
core [16]. Again, the absence of cross-ring cleavage ions suggested
that the two terminal HexNAcs were 3-linked.
Proton NMR spectroscopy of fractions C:tetra-I, C:tetra-II
and C:hexa
The anomeric region of the 600 MHz spectrum of fraction C:tetra-
I is shown as two partial spectra on top of the corresponding COSY
sections in Fig. 4, and in Fig. 5 the low field portion of the anomeric
region (A; C:tetra-I) is compared to the corresponding section of the
same fraction having been further purified (B; C:tetra-II). From Figs. 4
and 5, and the spectrum of the following fraction C:penta (not shown),
which almost exclusively turned out to contain the Forssman
pentaglycosylceramide (GalNAca3GalNAcß3Gala4Galß4Glcß1Cer)
[17], it is concluded that the spectrum in Fig. 5B represents two
different species, one of which is the Forssman pentaglycosylceramide
(labeled D), and a second one representing a novel four-sugar
compound (labeled B) to be characterized below. It can be further
concluded that the C:tetra-I fraction shown in Figs. 4 and 5A contains
two additional minor species besides compounds B and D (labeled A
Figure 1. Binding of F4 fimbriae and F4-fimbriated Escherichia coli to erythrocyte non-acid glycosphingolipid mixtures. Chemical
detection by anisaldehyde (A), and autoradiograms obtained by binding of 125I-labeled F4ab fimbriae (B), F4ac fimbriae (C), F4ad fimbriae (D), and
35S-labeled F4ab-expressing E. coli (E), F4ac-expressing E. coli (F), and F4ad-expressing E. coli (G). The lanes were: Lane 1, non-acid glycosphingo-
lipids of human erythrocytes blood group AB, 80 mg; Lane 2, non-acid glycosphingolipids of chicken erythrocytes, 40 mg; Lane 3, non-acid
glycosphingolipids of guinea pig erythrocytes, 40 mg; Lane 4, non-acid glycosphingolipids of rabbit erythrocytes, 40 mg; Lane 5, non-acid
glycosphingolipids of porcine erythrocytes, 40 mg; Lane 6, reference globotetraosylceramide (GalNAcß3Gala4Galß4Glcß1Cer) of human erythrocytes,
4 mg. The major compounds visualized with anisaldehyde in (A) are marked with Roman numbers, and the corresponding glycosphingolipid
structures are given to the right of the chromatogram.
doi:10.1371/journal.pone.0023309.g001
Figure 2. Binding of F4ad fimbriae to slow-migrating non-acid
glycosphingolipid fractions isolated from chicken erythro-
cytes. Chemical detection by anisaldehyde (A), and autoradiograms
obtained by binding of 125I-labeled F4ad fimbriae (B). The lanes were: Lane
1, non-acid glycosphingolipids of chicken erythrocytes, 40 mg; Lanes 2–9,
glycosphingolipid fractions isolated from chicken erythrocytes, 0.5–2 mg/lane.
doi:10.1371/journal.pone.0023309.g002
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and C, respectively). Compound A is easily identified from the NMR
literature [17], mass spectrometry data, and the present COSY
data, as globoside (GalNAcß3Gala4Galß4Glcß1Cer). The terminal
GalNAcß3 is thus clearly separated from internal ones by the H1/H2
connectivity seen at 4.509/3.75 ppm (see Table 1), as opposed to the
corresponding values seen e.g. for the GalNAcß3 of the Forssman
pentaglycosylceramide (4.511/4.03 ppm) [17]. Furthermore, the
anomeric resonances of the Gala4 residues stemming from globoside
and the Forssman pentaglycosylceramide are seen as expected at
4.796 ppm and 4.781 ppm, respectively, whereas the terminal
GalNAca3 of the Forssman pentaglycosylceramide is readily found
at 4.692 ppm, overlapping with another GalNAca3 anomeric
resonance from the novel B compound. The H1/H2 connectivities
arising from the Galß4Glcß1 segments of these two compounds are
also clearly revealed as seen in the right panel of Fig. 4.
From the mass spectrometry data discussed above it was
concluded that the four-sugar compound has the sequence
HexNAc-HexNAc-Hex-Hex with both HexNAc residues being
3-linked. Inspection of Fig. 5B shows that the novel compound
contains one a- and one ß-HexNAc at ppm values (4.699 ppm and
4.594 ppm, respectively) consistent with their identity being a
terminal GalNAca3 and an internal GalNAcß3. The H1/H2
connectivity of the GalNAcß3 residue is only consistent with a
penultimate position for this sugar residue (Table 1). Furthermore,
a 4-linked GalNAc can be excluded since the preceding Galß4
residue would in this case be expected to display an H1/H2
connectivity around 4.21/3.23 ppm as in e.g. gangliotetraosylcer-
amide (Galß3GalNAcß4Galß4Glcß1Cer) [18]. However, no such
connectivity is observed in Fig. 4. The two remaining residues
(Hex-Hex) are most likely represented by a Galß4Glcß1 segment
Figure 3. Characterization of the F4 fimbriae binding tetra- and hexaglycosylceramide of chicken erythrocytes. (A) Base peak
chromatogram from LC-ESI/MS of the saccharide obtained by digestion with Rhodococcus endoglycoceramidase II of the F4-binding
glycosphingolipid fraction C:tetra-II from chicken erythrocytes. (B) MS2 spectrum of the ion at m/z 747 (retention time 21.4 min). (C) Base peak
chromatogram from LC-ESI/MS of the saccharide obtained by digestion with Rhodococcus endoglycoceramidase II of the F4-binding
glycosphingolipid fraction C:hexa from chicken erythrocytes. (D) MS2 spectrum of the ion at m/z 1112 (retention time 23.0 min).
doi:10.1371/journal.pone.0023309.g003
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where the anomeric resonances, however, are obscured by the
corresponding resonances from globoside and the Forssman
pentaglycosylceramide. The sequence of compound B is thus
concluded to be GalNAca3GalNAcß3Galß4Glcß1Cer.
Further inspection of Fig. 5A reveals three minor additional
anomeric resonances yet to be assigned to specific residues: the one
to lowest field is an a-signal at 4.827 ppm revealing an H2 signal
at 3.75 ppm thus indicating a Gala4 residue [19]; the second one
is a ß-signal at 4.645 ppm having the H2 resonance at 3.40 ppm,
which identifies this sugar as a GlcNAcß3 residue which probably
stems from a small percentage of neolactohexaosylceramide (the
closeby intensity seen at 4.66/3.37 ppm in Fig. 4 is an artefact due
to the residual HDO resonance); the third one is also a ß-signal
seen partially overlapping the GalNAcß3 resonances stemming
from globoside and the Forssman pentaglycosylceramide on the
low-field side. This resonance is more clearly seen in the COSY
spectrum and the H1/H2 connectivity at 4.524/4.03 ppm
identifies also this sugar as an internal GalNAcß3 residue. The
observation that the Gala4 H1 resonance is shifted almost
0.3 ppm to lower field is suggestive of an extended galabiaosylcer-
amide based four-sugar structure. Galabiaosylceramide has
previously been identified in chicken erythrocytes [15] and
characterized by NMR [20]. In such a case the H1/H2
connectivity of Galß1 is expected around 4.08/4.29 ppm, which
is exactly where a cross-peak of appropriate intensity is seen in
Fig. 4. In the absence of a clearly distinguishable anomeric
resonance that may conclusively identify the sugar in the fourth
position, it may be inferred that a GalNAca3 residue whose
resonances completely overlap those of the corresponding residue
Figure 4. Proton NMR of the F4-binding glycosphingolipid (fraction C:tetra-I) from chicken erythrocytes. Anomeric regions of the
600 MHz proton NMR of the F4-binding glycosphingolipid (fraction C:tetra-I) from chicken erythrocytes (30uC). The sample was dissolved in dimethyl
sulfoxide-D2O (98:2, by volume) after deuterium exchange. Below each section the corresponding DQF-COSY spectrum showing mainly the H1/H2
connectivities are displayed. Connectivities stemming from the same structure are color-coded by superimposed ellipses. Thus, the Forssman
pentaglycosylceramide (Fo; GalNAca3GalNAcß3Gala4Galß4Glcß1Cer) and globoside (GbO4; GalNAcß3Gala4Galß4Glcß1Cer) are black, whereas the
two novel four-sugar compounds B and C are colored blue and red, respectively. Furthermore, only connectivities other than H1/H2 ones are denoted
as such.
doi:10.1371/journal.pone.0023309.g004
Figure 5. Proton NMR of fraction C:tetra-I and fraction C-tetra-
II from chicken erythrocytes. Low-field part of the anomeric regions
of the 600 MHz spectra of fraction C:tetra-I (A) and fraction C-tetra-II (B).
The arrows in (A) indicate which resonances that have disappeared in
(B) and these are labeled according to the scheme in Table 1. Likewise,
the remaining resonances in (B) are also labeled as in Table 1.
doi:10.1371/journal.pone.0023309.g005
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in the Forssman antigen is the only viable assumption, thus
suggesting that the final structure should be GalNAca3Gal-
NAcß3Gala4Galß1Cer (compound C). From a mass spectrometry
point of view this sequence also explains why only one four-sugar
compound could be detected.
NMR data for the C:hexa fraction was also obtained (not shown),
but due to the low amount of material in this case, the spectral quality
was rather poor. However, the signal to noise ratio was sufficient
enough in order to clearly identify the Forssman pentaglycosylcer-
amide, along with a second compound having three HexNAc
residues whose identities are GalNAca3 at 4.70 ppm, GlcNAcß3 at
4.65 ppm and GalNAcß3 at 4.596 ppm. The mass spectrometry of
fraction C:hexa revealed the presence of the sequence HexNAc-
HexNAc-Hex-HexNAc-Hex-Hex. The two residues closest to the
ceramide are most likely Galß4Glcß1, which leaves the third Hex that
most likely can be assigned to a second Galß4 residue. Taken together
these data allows the structure to be identified as GalNAca3Gal-
NAcß3Galß4GlcNAcß3Galß4Glcß1Cer (compound E). This novel
glycosphingolipid is thus the x2 glycosphingolipid elongated by a
GalNAca3 residue. The x2 glycosphingolipid has previously been
characterized by NMR [21], and the chemical shifts are in accord
with the ones found here (Table 1). It is noteworthy that the shifts of
the two terminal HexNAc residues are identical to the ones found for
compound B.
Thus, by mass spectrometry and proton NMR the F4-binding
fraction C:tetra-II was characterized by the presence of the Forssman
pentaglycosylceramide (GalNAca3GalNAcß3Gala4Galß4Glcß1Cer)
and GalNAca3GalNAcß3Galß4Glcß1Cer, and the F4-binding
fraction C:hexa by the presence of the Forssman pentaglycosylcer-
amide and GalNAca3GalNAcß3Galß4GlcNAcß3Galß4Glcß1Cer.
GalNAca3GalNAcß3Galß4Glcß1Cer, GalNAca3GalNAcß3Galß4-
GlcNAcß3Galß4Glcß1Cer, and the GalNAca3GalNAcß3Gala4-
Galß1Cer found in fraction C:tetra-I, are novel glycosphingolipid
structures. Since no binding of the F4 fimbriae to reference Forssman
pentaglycosylceramide was obtained (see below), GalNAca3Gal-
NAcß3Galß4Glcß1Cer and GalNAca3GalNAcß3Galß4GlcNAc-
ß3Galß4Glcß1Cer are the tetra- and hexaosylceramides recognized
by the F4 fimbriae, and the GalNAca3GalNAcß3Galß sequence is
the minimum epitope required for binding to occur. Potentially, the
minor GalNAca3GalNAcß3Gala4Galß1Cer of fraction C:tetra:I
could also be recognized by the F4 fimbriae. However, since the
terminal trisaccharide of this tetraglycosylceramide is identical with
the terminal trisaccharide of the non-binding Forssman pentaglyco-
sylceramide, a binding of F4 fimbriae to GalNAca3Gal-
NAcß3Gala4Galß1Cer is less likely.
Binding of F4 fimbriae and F4-fimbriated E. coli to
glycosphingolipids of pig intestinal epithelium
Thereafter, the binding of F4ab, F4ac and F4ad fimbriae and
F4-fimbriated E. coli to mixtures of total acid and non-acid
glycosphingolipids isolated from mucosal scrapings of newborn
piglet and adult pig intestines was tested. No binding of the F4ad
fimbriae or F4ad-expressing E. coli to the glycosphingolipids of pig
intestinal epithelium occurred (not shown). In contrast, a specific
binding of the F4ab fimbriae and the F4ab-fimbriated bacteria to
some fast-migrating glycosphingolipids in the acid fractions was
observed (Fig. 6B and C, lanes 2 and 4, marked with * in 6A). In
the non-acid fractions, a compound migrating in the monoglyco-
sylceramide region was recognized by both the F4ab and the F4ac
fimbriae and the bacterial cells (Fig. 6, lanes 1, 2 and/or 5, marked
with ** in 6A). In addition, the F4ab fimbriae and the F4ab-
expressing E. coli recognized a compound migrating in the
triglycosylceramide region (Fig. 6B and C, lanes 1 and 3, marked
with *** in 6A).
Table 1. Summary of glycosphingolipid structures identified by NMR in the 4–6 sugar region of fractions C:tetra-I, C:tetra-II, and
C:hexa in chicken erythrocytes (the identity of the anomeric and other ring proton resonances are given in the NMR spectra shown
in Figs. 4 and 5).
Structure Trivial name VI V IV III II* I*
A Globoside GalNAcß3 Gala4 Galß4 Glcß1 Cer
H1 4.509 4.796 4.244 4.165
H2 3.75 3.76 3.43 3.03
H3 3.48
B GalNAca3 GalNAcß3 Galß4 Glcß1 Cer
H1 4.699 4.594 — —
H2 4.10 3.95
H3 3.55 3.44
C GalNAca3 GalNAcß3 Gala4 Galß1 Cer
H1 ,4.70 4.524 4.827 4.077
H2 4.03 3.75 3.29
H3 3.48
D Forssman pentaglycosylceramide GalNAca3 GalNAcß3 Gala4 Galß4 Glcß1 Cer
H1 4.692 4.511 4.781 4.254 4.195
H2 4.10 4.03 3.76 3.29 3.02
H3 3.55 3.48
E Extended x2 GalNAca3 GalNAcß3 Galß4 GlcNAcß3 Galß4 Glcß1 Cer
H1 4.70 4.596 ,4.26 4.65 ,4.26 —
*Chemical shift values are in some cases not given due to low intensities and severe resonance overlap.
doi:10.1371/journal.pone.0023309.t001
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Characterization of the acid porcine intestinal
glycosphingolipids recognized by F4ab fimbriae
In order to characterize the F4ab-binding acid glycosphingo-
lipids of newborn piglet intestinal epithelium, this fraction was
analyzed by TLC-FAB-MS (Figure S3). Thereby, the more slow-
migrating F4ab-binding glycosphingolipid was tentatively identi-
fied as sulfated dihexosylceramide, while the fast-migrating F4ab-
binding glycosphingolipid was tentatively identified as sulfated
monohexosylceramide.
To confirm the identity of the sulfated glycosphingolipids
recognized by the F4ab fimbriae, the binding of these fimbriae to a
panel of reference sulfated glycosphingolipids was next evaluated
(Fig. 7, and summarized in Table 2). Here the F4ab fimbriae
recognized sulfatide (SO3-3Galß1Cer) with variant ceramide com-
position (Fig. 7, lanes 1–3), along with binding to sulf-lactosylcer-
amide (SO3-3Galß4Glcß1Cer; lane 4), while no binding to sulf-
gangliotetraosylceramide (SO3-3Galß3GalNAcß4Galß4Glcß1Cer;
lane 5) or cholesterol-sulfate (not shown) occurred.
Thus, the F4ab-binding acid glycosphingolipids of piglet small
intestinal epithelium were identified as sulfatide and sulf-lactosylcer-
amide. When using reference glycosphingolipids, the F4ab fimbriae
bound to sulfatide with both sphingosine and phytosphingosine long-
chain bases, and both hydroxy and non-hydroxy fatty acids, i.e. the
ceramide composition did not influence the binding.
Isolation and characterization of the F4ab/F4ac fimbriae
binding monoglycosylceramide from pig small intestinal
mucosa
The binding-active monoglycosylceramide was isolated by HPLC
of the total non-acid glycosphingolipid fraction from adult pig small
intestinal mucosa, and the preparative procedure was monitored by
binding of radiolabeled F4ab and F4ac fimbriae on thin-layer
chromatograms. Pooling of the F4ab/F4ac binding monoglycosyl-
ceramide fractions yielded 5.2 mg (denoted fraction P:mono).
Characterization of fraction P:mono identified galactosylcer-
amide (Galß1Cer) with sphingosine and hydroxy 24:0 fatty acid as
the binding-active component. This conclusion is based on the
following observations:
I) On thin-layer chromatograms the binding-active
monoglycosylceramide migrated as a distinct band at
the lower margin of the monoglycosylceramide region
(Fig. 8B–D, lane 3).
II) The negative ion FAB mass spectrum of fraction
P:mono (Fig. 8E) had a major molecular ion at m/z 826
identifying a monohexosylceramide with sphingosine
and hydroxy 24:0 fatty acid. A major ceramide ion at m/
z 664, obtained by elimination of the carbohydrate unit,
was also present (not shown). Thus, the glycosphingo-
lipid was identified as a monohexosylceramide with
sphingosine and hydroxy 24:0 fatty acid.
IV) The proton NMR spectrum of fraction P:mono (data
not shown) revealed two anomeric proton resonances:
one belonging to Galß1Cer at 4.066 ppm (,60%), a
shift consistent with the presence of hydroxy fatty acid,
and the other belonging to Glcß1Cer with non-hydroxy
fatty acids at 4.113 ppm (,40%) [22]. Both species were
found to contain a sphingosine base in line with mass
spectrometry data.
Using the same techniques the non-binding monoglycosylcer-
amide fractions displayed in Fig. 8, lanes 2, 4 and 5 were
characterized as glucosylceramide (Glcß1Cer) with mainly sphin-
gosine and hydroxy 24:0 fatty acid, glucosylceramide with
sphingosine and hydroxy 16:0 fatty acid and phytosphingosine
with hydroxy 24:1 fatty acid together with galactosylceramide with
phytosphingosine with hydroxy 16:0-24:0 fatty acids, respectively
(data not shown).
Figure 6. Binding of F4ab and F4ac fimbriae, and F4ab- and
F4ac-fimbriated Escherichia coli, to mixtures of glycosphingo-
lipids from porcine intestinal mucosa. Chemical detection by
anisaldehyde (A), and autoradiograms obtained by binding of F4ab
fimbriae (B), F4ac fimbriae (C), F4ab-expressing E. coli (D), and F4ac-
expressing E. coli (E). The lanes were: Lane 1, non-acid glycosphingo-
lipids of 3-day old piglet small intestinal mucosa, 40 mg; Lane 2, acid
glycosphingolipids of 3-day old piglet small intestinal mucosa, 20 mg;
Lane 3, non-acid glycosphingolipids of adult pig 1 small intestinal
mucosa, 40 mg; Lane 4, acid glycosphingolipids of adult pig 1 small
intestinal mucosa, 40 mg; Lane 5, non-acid glycosphingolipids of adult
pig 2 small intestinal mucosa, 40 mg. The Roman numbers to the left of
panel A indicate the approximate number of carbohydrate residues in
the bands in the non-acid fractions (lanes 1, 3 and 5). The approximate
migration level of the F4ab-/F4ac-binding compounds have been
marked with *, **, and *** in panel A.
doi:10.1371/journal.pone.0023309.g006
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Thus, of the monoglycosylceramides from pig intestine the
F4ab- and F4ac-fimbriae bound to galactosylceramide with a
distinct preference for the species with sphingosine and hydroxy
24:0 fatty acid.
Isolation and characterization of the F4ab fimbriae
binding non-acid triglycosylceramide of pig small
intestinal mucosa
The F4ab binding triglycosylceramide was isolated by chroma-
tography on an Iatrobeads column, and the fractions obtained
were tested for F4ab binding activity using 125I-labeled F4ab
fimbriae. The fractions obtained were pooled into four fractions
according to thin-layer chromatographic resolution and binding of
F4ab fimbriae (Fig. 9A, lanes 2–5). The fraction designated
fraction P:tri:I (1.7 mg; lane 2) had no F4ab binding activity.
Fractions P:tri:II (0.9 mg; lane 3) and P:tri:III (1.0 mg, lane 4)
were recognized by the F4ab fimbriae, while fractions P:tri: IV
(0.3 mg; lane 5) was non-binding.
Structural characterization of fraction P:tri:III demonstrated
that the F4ab binding glycosphingolipid was globotriaosylcera-
mide (Gala4Galß4Glcß1Cer) with phytosphingosine and hydroxy
24:0 fatty acid. This conclusion is based on the following
observations:
I) The binding-active compound migrated in the
triglycosylceramide region on thin-layer chromatograms
(Fig. 6, lanes 1 and 3).
II) Fractions P:tri:I, P:tri: II and P:tri:III were analyzed
by LC-ESI/MS using polyamine columns (to be
published separately). Thereby, the non-binding fraction
P:tri:I gave a series of [M-H+]2 ions at m/z 1022, m/z
1078, m/z 1106, and m/z 1134, corresponding to a
Figure 7. Binding of F4ab fimbriae to reference glycosphingo-
lipids. Chemical detection by anisaldehyde (A), and autoradiograms
obtained by binding of 125I-labeled F4ab fimbriae (B). The lanes were:
Lane 1, sulfatide (SO3-3Galß1Cer) with d18:1-24:1 ceramide, 4 mg; Lane
2, sulfatide with d18:1-h16:0 ceramide, 4 mg; Lane 3, sulfatide with
t18:0-h24:0 ceramide, 4 mg; Lane 4, sulf-lactosylceramide (SO3-
3Galß4Glcß1Cer) with t18:0-h16:0 ceramide, 4 mg; Lane 5, reference
sulf-gangliotetraosylceramide (SO3-3Galß3GalNAcß4Galß4Glcß1Cer),
4 mg. The glycosphingolipids visualized with anisaldehyde in (A) are
marked with Roman numbers, and the corresponding glycosphingo-
lipid structures are given below the chromatograms.
doi:10.1371/journal.pone.0023309.g007
Table 2. Summary of glycosphingolipid binding specificities of F4ab, F4ac and F4ad fimbriae.
No. Trivial name Structure F4aba F4aca F4ada
I. Chicken erythrocyte
glycosphingolipids
1. Galactosylceramide Galß1Cer +++ +++ 2
2. GalNAca3GalNAcß3Galß4Glcß1Cer +++ +++ +++
3. GalNAca3GalNAcß3Galß4GlcNAcß3Galß4Glcß1Cer +++ +++ +++
II. Porcine intestinal
glycosphingolipids
1. Galactosylceramide Galß1Cer +++ +++ 2
2. Sulfatide SO3-3Galß1Cer +++ + 2
3. Sulf-lactosylceramide SO3-3Galß4Glcß1Cer +++ 2 2
4. Globotriaosylceramide (t18:0-h24:0) Gala4Galß4Glcß1Cer +++ 2 2
III. Reference
glycosphingolipids
1. Lactosylceramide (t18:0-h16:0-h24:0) Galß4Glcß1Cer +++ +++ +++
2. Galabiaosylceramide Gala4Galß1Cer +++ 2 2
3. Isoglobotriaosylceramide Gala3Galß4Glcß1Cer 2 2 +
4. Gangliotriaosylceramide GalNAcß4Galß4Glcß1Cer 2 2 +++
5. Gangliotetraosylceramide Galß3GalNAcß4Galß4Glcß1Cer 2 2 +++
6. Neolactotetraosylceramide Galß4GlcNAcß3Galß4Glcß1Cer 2 2 +
aF4ab denotes bindings obtained with both F4ab fimbriae and F4ab-fimbriated E. coli, F4ac bindings obtained with both F4ac fimbriae and F4ac-fimbriated E. coli, and
F4ad bindings obtained with both F4ad fimbriae and F4ad-fimbriated E. coli.
Binding is defined as follows: +++ denotes an intense and highly reproducible staining when 4 mg of the glycosphingolipid was applied on the thin-layer
chromatogram, + denotes an occasional staining,while 2 denotes no binding even at 4 mg.
doi:10.1371/journal.pone.0023309.t002
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glyco-sphingolipid with three Hex and sphingosine
with non-hydroxy 16:0, 20:0, 22:0 and 24:0 fatty
acids, respectively (Fig. 9C). A [M-H+]2 ion at m/z
1022, indicating a trihexosylceramide with sphingosine
with non-hydroxy 16:0 fatty acid, was also present in the
mass spectra of fractions P:tri: II and P:tri:III (Fig. 9D
and E). However, these F4ab binding fractions also had
a major peak at m/z 1168 indicating a glycosphingolipid
with three Hex and phytosphingosine and hydroxy 24:0
fatty acid. This was confirmed by the series of fragment
ions at m/z 1006 (Y2; 1168-Hex), m/z 844 (Y1; 1168-
Hex-Hex) and m/z 682 (Y0; 1168-Hex-Hex-Hex)
obtained by MS2 of the ion at m/z 1168 (Fig. 9F).
III) The proton NMR spectrum of the F4ab-fimbriae
binding fraction P:tri:III (not shown) revealed a single
anomeric signal at 4.78 ppm (Gala4), several overlap-
ping signals centered around 4.26 ppm (Galß4) and
three overlapping signals in the range 4.19–4.21 ppm
(Glcß1), respectively, readily identifying this compound
as globotriaosylceramide (Gala4Galß4Glcß1Cer)
through comparison with previously published spectra
[23].
The binding of F4ab fimbriae to a panel of reference
glycosphingolipids related to globotriaosylceramide was thereafter
evaluated, in order to further investigate the requirements for the
Figure 8. Characterization of the F4ab and F4ac binding
monoglycosylceramides from porcine small intestinal mucosa.
Chemical detection by anisaldehyde (A), and autoradiograms obtained
by binding of 125I-labeled F4ab fimbriae (B), 35S-labeled F4ab-expressing
E. coli (C), and F4ac-expressing E. coli (D). The glycosphingolipids were
separated using chloroform/methanol/water 65:25:4 (by volume) as
solvent system. The lanes were: Lane 1, non-acid glycosphingolipids of
adult pig 1 small intestinal mucosa, 40 mg; Lanes 2–5, monoglycosylcer-
amides isolated from adult pig small intestinal mucosa, 4 mg/lane; Lane 6,
reference galactosylceramide (Galß1Cer) with d18:1-h18:0-h24:0 cer-
amide, 4 mg. (E) Negative ion FAB mass spectrum of fraction P:mono from
adult pig small intestinal mucosa. Above the spectrum is an interpreta-
tion formula representing the species with d18:1-h24:0 ceramide. The
analysis was done as described in the ‘‘Materials and Methods’’ section.
doi:10.1371/journal.pone.0023309.g008
Figure 9. Characterization of the F4ab fimbriae binding
triglycosylceramides from porcine small intestinal mucosa.
Chemical detection by anisaldehyde (A), and autoradiogram obtained
by binding of 125I-labeled F4ab fimbriae (B). The lanes were: Lane 1,
non-acid glycosphingolipids of human erythrocytes, 40 mg; Lanes 2–5,
fractions P:tri:I, P:tri:II, P:tri:III and P:tri:IV, respectively, from pig small
intestinal epithelium, 4 mg/lane. (C) ESI mass spectrum of fraction P:tri:I
from pig small intestinal epithelium. (D) ESI mass spectrum of fraction
P:tri:II from pig small intestinal epithelium. (E) ESI mass spectrum of
fraction P:tri:III from pig small intestinal epithelium. (F) MS2 spectrum of
the [M-H]2 ion at m/z 1168 of fraction P:tri:III. (G) Interpretation formula
representing the species with t18:0-h24:0 ceramide.
doi:10.1371/journal.pone.0023309.g009
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globotriaosylceramide binding by these fimbriae (Fig. 10). Here, the
F4ab fimbriae bound to globotriaosylceramide with phytosphingo-
sine and hydroxy or non-hydroxy fatty acids (lanes 2–4), and to
lactosylceramide with phytosphingosine and hydroxy fatty acids (lane
6). However, isoglobotriaosylceramide (lane 5) was not recognized
although it had phytosphingosine and hydroxy fatty acids, and no
binding to globotriaosylceramide or lactosylceramide with sphingo-
sine and non-hydroxy fatty acids (lane 1 and lane 7) occurred.
Binding of F4 fimbriae and F4-fimbriated E. coli to
reference glycosphingolipids
To further investigate the structural requirements for F4 fimbriae
glycosphingolipid recognition, the binding of F4-expressing E. coli,
and F4 fimbriae, to a number of reference glycosphingolipids
related to the binding-active compounds was next examined. The
results are exemplified in Figs. 11 and 12, and summarized in Table
S1. Here, lactosylceramide (Galß4Glcß1Cer; Fig. 11, lane 4, upper
band, and Fig. 12, lane 3, upper band) with phytosphingosine and
hydroxy fatty acid was recognized by all three subtypes of F4.
However, for the remaining binding-active compounds, the
recognition profiles differed between the F4 variants. Galactosylcer-
amide (Galß1Cer; Fig. 11, lane 3, upper band, and Fig. 12, lane 2,
upper band) was the preferred ligand for F4ac fimbriae and F4ac-
expressing bacteria, and binding to other glycosphingolipids, as e.g.
sulfatide (SO3-Galß1Cer; Fig. 11, lane 1, upper band), by the F4ac
subtype occurred very occasionally. Galactosylceramide was also
recognized by the F4ab fimbriae and F4ab-fimbriated bacteria. The
F4ab subtype also bound to sulfatide (Fig. 11, lane 1, upper band)
and to globotriaosylceramide (Gala4Galß4Glcß1Cer; Fig. 11, lane
6). In addition, galabiaosylceramide (Gala4Galß1Cer; Fig. 11, lane
5, upper band) was recognized by F4ab. Finally, the most divergent
subtype was the F4ad, where both the fimbriae and the bacterial
cells bound to gangliotriaosylceramide (GalNAcß4Galß4Glcß1Cer;
Fig. 11, lane 7, and Fig. 12, lane 6) and gangliotetraosylceramide
(Galß3GalNAcß4Galß4Glcß1Cer; Fig. 11, lane 3, lower band, and
Fig. 12, lane 7), and occasionally to isoglobotriaosylceramide
(Gala3Galß4Glcß1Cer; Fig. 12, lane 5) and neolactotetraosylcera-
mide (Galß4GlcNAcß3Galß4Glcß1Cer; Fig. 11, lane 2, lower band).
Glycosphingolipid recognition of F4ab deletion mutant
fimbriae
To evaluate the relative roles of different F4ab subunits in the
glycosphingolipid interaction, fimbriae were isolated from recom-
binant bacteria expressing F4ab fimbriae with deletions of FaeH,
FaeI and FaeJ. In glycosphingolipid binding assays, the binding
patterns obtained with these deletion mutant fimbriae were
identical to that of the native F4ab fimbriae (Figure S4). In
Figure 10. Binding of F4ab fimbriae to non-acid reference
glycosphingolipids. Chemical detection by anisaldehyde (A), and
autoradiogram obtained by binding of 125I-labeled F4ab fimbriae (B).
The lanes were: Lane 1, globotriaosylceramide (Gala4Galß4Glcß1Cer) of
human erythrocytes with d18:1-16:0 and d18:1-24:0 ceramide, 4 mg;
Lane 2, globotriaosylceramide of rat intestine with t18:0-20:0-24:0
and t18:0-h22:0-24:0 ceramide, 2 mg; Lane 3, globotriaosylceramide of
human meconium with t18:0-22:0-24:0 ceramide, 2 mg; Lane 4,
globotriaosylceramide of human kidney with d18:1-h16:0 and t18:0-
h22:0-h24:0 ceramide, 2 mg; Lane 5, isoglobotriaosylceramide (Gala3-
Galß4Glcß1Cer) of cat intestine with t18:0-h22:0-h24:0 ceramide, 2 mg;
Lane 6, lactosylceramide (Galß4Glcß1Cer) of dog intestine with t18:0-
h16:0-h24:0 ceramide, 4 mg; Lane 7, lactosylceramide of human
neutrophils with d18:1-16:0 and d18:1-24:1 ceramide, 4 mg.
doi:10.1371/journal.pone.0023309.g010
Figure 11. Binding of F4 fimbriae to reference glycosphingo-
lipids. Chemical detection by anisaldehyde (A), and autoradiograms
obtained by binding of 125I-labeled F4ab fimbriae (B), F4ac fimbriae (C),
and F4ad fimbriae (D). The lanes were: Lane 1, sulfatide (SO3-3Galß1Cer)
of human intestine with t18:0-h24:0 ceramide, 4 mg, and globotetrao-
sylceramide (GalNAcß3Gala4Galß4Glcß1Cer) of human erythrocy-
tes with d18:1-16:0-24:0 ceramide, 4 mg; Lane 2, glucosylceramide
(Glcß1Cer) of porcine kidney with d18:1/t18:0-16:0-24:0 ceramide, 4 mg,
and neolactotetraosylceramide (Galß4GlcNAcß3Galß4Glcß1Cer) of hu-
man neutrophils with d18:1-16:0 and 24:1 ceramide, 4 mg; Lane 3,
galactosylceramide (Galß1Cer) of bovine brain from Sigma-Aldrich with
d18:1-h18:0-h24:0 ceramide, 4 mg, and gangliotetraosylceramide
(Galß3GalNAcß4Galß4Glcß1Cer) of mouse intestine with t18:0-h16:0
and h24:0 ceramide, 4 mg; Lane 4, lactosylceramide (Galß4Glcß1Cer) of
dog intestine with t18:0-h16:0-h24:0 ceramide, 4 mg, and B5 pentagly-
cosylceramide (Gala3Galß4GlcNAcß3Galß4Glcß1Cer) of rabbit erythro-
cytes with d18:1-16:0 and 24:0 ceramide, 4 mg; Lane 5, galabiaosylcer-
amide (Gala4Galß1Cer) (synthetic) with d18:1-16:0-18:0 ceramide, 4 mg,
and P1 pentaglycosylceramide (Gala4Galß4GlcNAcß3Galß4Glcß1Cer) of
human erythrocytes with d18:1-16:0 and 24:0 ceramide, 4 mg; Lane 6,
globotriaosylceramide (Gala4Galß4Glcß1Cer) of rat intestine with
t18:0-h22:0-h24:0 ceramide, 4 mg; Lane 7, gangliotriaosylceramide
(GalNAcß4Galß4Glcß1Cer) of guinea pig erythrocytes with d18:1-16:0
and 24:0 ceramide, 4 mg. The glycosphingolipids visualized with
anisaldehyde in (A) are marked with Roman numbers, and the
corresponding glycosphingolipid structures are given below the
chromatograms.
doi:10.1371/journal.pone.0023309.g011
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addition, bacteria expressing F4ab fimbriae with deletions of
FaeH, FaeI and FaeJ bound in the same manner as the F4ab-
positive wild type E. coli (Fig. S4). Thus, the minor F4ab subunits
FaeH, FaeI and FaeJ are not involved in F4ab glycosphingolipid
recognition.
Discussion
Microbes often utilize cell surface glycoconjugates for target cell
recognition, and the binding of bacterial pathogens to host cell
glycoconjugates can be mediated by both fimbrial and non-
fimbrial adhesins. Here we have investigated the glycosphingolipid
recognition of F4 fimbriae, a major virulence factor of entero-
toxigenic E. coli causing neonatal and post-weaning diarrhea. The
glycosphingolipid binding preferences of the three F4 variants are
summarized in Table 2.
In the initial studies using a panel of erythrocyte glycosphin-
golipids from different species we found a distinct binding of all
three F4 variants to three chicken erythrocyte non-acid glyco-
sphingolipids, migrating as mono-, tetra- and hexaglycosylcer-
amides. Previous studies of chicken erythrocyte glycosphingolipids
have demonstrated the presence of galactosylceramide, lactosyl-
ceramide and the Forssman pentaglycosylceramide in this source
[15]. The binding of F4ab and F4ac to reference galactosylcer-
amide, and galactosylceramide isolated from porcine intestine,
suggested that the binding-active monoglycosylceramide from
chicken erythrocytes was galactosylceramide. It should here be
noted that no binding of the F4ad fimbriae to galactosylceramide
occurred.
The F4ab/ac/ad-binding tetra- and hexaglycosylceramides of
chicken erythrocytes were characterized by mass spectrometry and
proton NMR as GalNAca3GalNAcß3Galß4Glcß1Cer and Gal-
NAca3GalNAcß3Galß4GlcNAcß3Galß4Glcß1Cer, both of which
are novel glycosphingolipid structures. GalNAca3GalNAca1-O-S/
T is the mucin type 5 core structure. However, in glycosphingolipids
the GalNAca3GalNAc moiety has previously only been character-
ized in the Forssman (GalNAca3GalNAcß3Gala4Galß4Glcß1Cer)
and the iso-Forssman (GalNAca3GalNAcß3Gala3Galß4Glcß1Cer)
pentaglycosylceramides [24,25]. No binding of the three F4 variants
to the Forssman pentaglycosylceramide was obtained, suggesting
that the binding epitope of the chicken tetra- and hexaglycosylcer-
amides was the GalNAca3GalNAcß3Galß moiety.
When using the erythrocyte panel a binding of F4ad fimbriae
and F4ad-fimbriated bacteria, but not the F4ab or F4ac variants,
to gangliotriaosylceramide (GalNAcß4Galß4Glcß1Cer), the major
non-acid glycosphingolipid of guinea pig erythrocytes was also
obtained.
However, there was no correlation between the hemagglutina-
tion patterns of the F4 variants and the glycosphingolipid bindings
obtained, suggesting that the glycosphingolipids are not involved
in the hemagglutination process.
Next, the binding of the F4 variants to glycosphingolipids from
the small intestinal epithelium of neonatal and adult pigs was
evaluated. Here, no binding of the F4ad fimbriae or F4ad-
fimbriated E. coli to the acid or non-acid glycosphingolipids of pig
intestine was obtained. However, for F4ab and F4ac two distinct
binding patterns were observed. The F4ac fimbriae and the F4ac-
expressing E. coli selectively bound to galactosylceramide with
sphingosine and hydroxy 24:0 fatty acid. This compound was also
recognized by the F4ab fimbriae and the F4ab-fimbriated bacteria.
Binding of F4ab fimbriae to galactosylceramide in piglet ileal
mucus has been described previously [26]. In addition, we found
that the F4ab fimbriae and F4ab-fimbriated bacteria also bound to
sulfatide, sulf-lactosylceramide and globotriaosylceramide with
phytosphingosine and hydroxy or non-hydroxy fatty acids.
Finally, when the binding to reference glycosphingolipids from
other sources was tested all three serotypes bound to lactosylceramide
(Galß4Glcß1Cer) with hydroxy ceramide. F4ab also recognized
galabiaosylceramide (Gala4Galß1Cer), in line with the binding to
porcine intestinal globotriaosylceramide (Gala4Galß4Glcß1Cer). In
addition, a selective binding of the F4ad fimbriae and the F4ad-
fimbriated E. coli, but not the F4ab or F4ac subtypes, to reference
gangliotriaosylceramide (GalNAcß4Galß4Glcß1Cer) and gangliote-
traosylceramide (Galß3GalNAcß4Galß4Glcß1Cer) was observed,
Figure 12. Binding of F4 fimbriae to reference glycosphingo-
lipids. Chemical detection by anisaldehyde (A), and autoradiograms
obtained by binding of 125I-labeled F4ab fimbriae (B), F4ac fimbriae
(C), and F4ad fimbriae (D). The lanes were: Lane 1, glucosylceramide
(Glcß1Cer) of porcine kidney with d18:1/t18:0-16:0-24:0 ceramide, 4 mg,
and globotetraosylceramide (GalNAcß3Gala4Galß4Glcß1Cer) of human
erythrocytes with d18:1-16:0-24:0 ceramide, 4 mg; Lane 2, galactosylcer-
amide (Galß1Cer) of bovine brain from Sigma-Aldrich with d18:1-h18:0-
h24:0 ceramide, 4 mg, and Forssman pentaglycosylceramide (GalNA-
ca3GalNAcß3Gala4Galß4Glcß1Cer) of dog intestine with d18:1-16:0 and
24:0 ceramide, 4 mg; Lane 3, lactosylceramide (Galß4Glcß1Cer) with
t18:0-h16:0-h24:0 ceramide of dog intestine, 4 mg, and neolactotetrao-
sylceramide (Galß4GlcNAcß3Galß4Glcß1Cer) of human neutrophils d18:1-
16:0 and 24:1 ceramide, 4 mg; Lane 4, lactosylceramide (Galß4Glcß1Cer)
with d18:1-16:0-24:1 ceramide of human neutrophils, 4 mg, and B5
pentaglycosylceramide (Gala3Galß4GlcNAcß3Galß4Glcß1Cer) of rabbit
erythrocytes with d18:1-16:0 and 24:0 ceramide, 4 mg; Lane 5, isoglobo-
triaosylceramide (Gala3Galß4Glcß1Cer) of cat intestine with t18:0-h22:0
and h24:0 ceramide, 4 mg; Lane 6, gangliotriaosylceramide (Gal-
NAcß4Galß4Glcß1Cer) of guinea pig erythrocytes with d18:1-16:0 and
2 4 : 0 c e r a m i d e , 4 mg ; L a n e 7 , g a n g l i o t e t r a o s y l c e r a m i d e
(Galß3GalNAcß4Galß4Glcß1Cer) of mouse intestine with t18:0-h16:0 and
h24:0 ceramide, 4 mg. The glycosphingolipids visualized with anisaldehyde
in (A) are marked with Roman numbers, and the corresponding
glycosphingolipid structures are given below the chromatograms.
doi:10.1371/journal.pone.0023309.g012
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and occasionally F4ad also bound to isoglobotriaosylceramide
(Gala3Galß4Glcß1Cer) and neolactotetraosylceramide (Galß4Glc-
NAcß3Galß4Glcß1Cer).
The major subunit FaeG is considered to be the adhesive subunit,
since sequence comparison of the genes encoding the minor and
major fimbrial subunits of the F4ab and F4ac variants showed that
the differences between these variants are confined to the faeG gene
[8]. This was supported by the fact that removal of all minor
fimbrial subunits by treatment of the F4 fimbriae with 2 M urea at
55uC did not affect the adhesive properties of the fimbriae [7].
In general, the F4ab and F4ac variants showed more similarities
in their glycosphingolipid recognition patterns compared to the
F4ad variant (Table S1 and Table 2). Comparative analysis of the
FaeG sequences from various F4ab, F4ac and F4ad antigenic
variant strains revealed that the amino acid sequences of the F4ab
and F4ac variants had a higher degree of homology (92%),
compared to the homology between the F4ad and F4ac (88%)
[27]. Within each F4 serotype, 96–100% homology in the FaeG
amino acid sequence was observed. Interestingly, an unusually
large carbohydrate binding site, consisting of an enlarged Ig-
domain with insertion of two a-helices and two ß-strands, is found
in the crystal structure of the F4ad variant of FaeG [28].
The repertoire of glycosphingolipids recognized by the F4ab
fimbriae is the most diverse, since this fimbrial subtype binds to
sulfatide, sulf-lactosylceramide, galactosylceramide, lactosylcera-
mide, galabiaosylceramide, globotriaosylceramide and the two
GalNAca3GalNAcß3Galß-terminated glycosphingolipids of chick-
en erythrocytes. Currently it is not known if all these compounds
are accomodated in the same carbohydrate binding site, and there
is no direct evidence for the involvement of the FaeG subunits in
the glycosphingolipid binding. However, in the glycosphingolipid
binding assays with fimbriae isolated from recombinant bacteria
expressing F4ab fimbriae with deletions of FaeH, FaeI or FaeJ, the
binding patterns obtained were identical to that of the native F4ab
fimbriae, and the bacteria expressing F4ab fimbriae with deletions
of FaeH, FaeI and FaeJ bound in the same manner as the
F4ab-positive wild type E. coli. These results suggest that the
glycosphingolipid binding is not mediated by the minor F4ab
fimbrial shaft subunit FaeH, or the minor FaeI and FaeJ subunits.
Binding studies with 125I-labeled recombinant F4ac/FaeG were
also attempted but gave only non-specific binding, probably due to
the low stability of this protein [29].
A switch in porcine brush border binding specificity was
obtained with E. coli expressing F4ac/F4ad chimeric FaeG
subunits, produced by reciprocal exchange of amino acids 125
to 163 [30]. It would be highly interesting to examine if a parallel
change in glycosphingolipid binding specificity occurs with
bacteria expressing these chimeric FaeG subunits.
The reason for the discrepancy between the results from the
previous F4 glycosphingo-lipid binding studies [11,12] and our
results is unclear. The focus of our study was the F4-binding
glycosphingolipids present in erythrocytes and the epithelial cells
of pig intestine. Payne et al. studied the binding of F4ab fimbriated
E. coli to reference glycosphingolipids from various sources on thin-
layer plates, along with binding of F4ab fimbriae to reference
glycosphingolipids in microtiter wells [11]. However, some of the
F4ab-binding glycosphingolipids of porcine intestine, as e.g.
sulfatide and sulf-lactosylceramide, were not included in that
study, and relatively high amounts (10 mg) of glycosphingolipids
were used in the chromatogram binding experiments. The main
difference between our study and the study by Grange et al. was
that biotinylated F4 fimbriae were used in the latter study [12].
The repertoire of porcine intestinal glycosphingolipids recog-
nized by the F4 fimbriae has, in different combinations,
been reported as putative receptors for a large number of other
microbes and microbial proteins. Notably, the PapG adhesin of
uropathogenic P-fimbriated E. coli and the verotoxin family (VT-1,
VT-2 and SLT-II) bind to globotriaosylceramide, with binding
dependent on the Gala4Gal epitope [31–33]. The PapG adhesin
and the pig edema disease toxin (VTE or SLT-IIv) also bind to
globotetraosylceramide [31,34,35], not recognized by F4ab, but
do not bind either galactosylceramide or sulfatide. That the
Gala4Gal motif is indeed recognized by the F4ab fimbriae is
shown by the parallel binding of this fimbrial subtype to
galabiaosylceramide. However, for the F4ab fimbriae a substitu-
tion of the terminal Gal with a ßGalNAc in 3-position is not
tolerated since globoside is non-binding.
Binding of uropathogenic F1c-fimbriated E. coli to galactosyl-
ceramide and globotriaosylceramide with hydroxy ceramides, but
not to sulfatide, has also been reported [36].
Sulfatide recognition is also a common theme in microbial
adhesion, and binding to sulfatide has been reported for e.g.
colonization factor antigen CS6 from human ETEC, Mycoplasma
pneumoniae, Bordetella pertussis, 987P-fimbriated E. coli, and Helico-
bacter pylori [37–42]. Interestingly, the subtype of the heat-stable
enterotoxin of E. coli which is primarily associated with diarrhea in
piglets (the STb subtype) also binds to sulfatide [43].
Finally, the binding pattern of F4ad, with recognition of
lactosylceramide with hydroxy ceramide, isoglobotriaosylcera-
mide, neolactotetraosylceramide, gangliotriaosylceramide and
gangliotetraosylceramide, has previously been reported for several
bacteria, both pathogens and members of the indigenous flora
[44]. It should, however, be noted that no binding of the F4ad
fimbriae and the F4ad-fimbriated E. coli to the porcine intestinal
glycosphingolipids was obtained, suggesting that the glycosphin-
golipid binding of F4ad has no relevance for bacterial attachment
to the porcine small intestinal epithelium.
The objective of present study was to characterize the
erythrocyte glycosphingolipids, and the glycosphingolipids of
porcine small intestinal epithelium, recognized by the F4ab,
F4ac and F4ad fimbriae, with the ultimate goal to create a
platform for synthesis of anti-adhesive substances. Candidate
receptors for adherence to the epithelial cells of porcine intestine
were identified as galactosylceramide, sulfatide, sulf-lactosylcer-
amide and globotriaosylceramide for F4ab, galactosylceramide
only for F4ac, while no binding of F4ad to the porcine intestinal
glycosphingolipid samples occurred. Still, F4ad binding neolacto-
tetraosylceramide has previously been identified in porcine
intestinal epithelial cells [13]. Whether the presence of the
glycosphingolipids recognized by the F4 variants is related to the
differences in the adhesiveness of F4 subtypes to pig intestinal
brush border membranes is currently investigated.
Furthermore, two candidate porcine intestinal glycoprotein
receptors for the F4 fimbriae have previously been identified, i.e. a
pair of mucin-type sialoglycoproteins (210 kDa or 240 kDa)
recognized by F4ab and F4ac, and a 74-kDa transferrin glycoprotein
recognized by F4ab (reviewed in [2,45]). Characterization of the
glycans of these F4 binding glycoproteins is an important next step.
Materials and Methods
Bacterial strains, culture conditions and labeling
The wild type F4ab-positive E. coli strains C585-80 (serotype
O8: K87: H19:F4ab, LT+), the wild type F4ac-positive E. coli
strain IMM01 (serotype O149:K91:F4ac, LT+, STb+) [46],
and the wild type F4ad-positive E. coli C1360-79 (serotype
O8:H10:F4ad) (15) were cultured on BHI agar plates (Oxoid,
Basingstoke, Hampshire, England) at 37uC for 18 h (7). E. coli K-
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12 (C600, l2 tonA21 thr leu-6 thi-1 supE44 lacY-1stable) [47]
containing the F4ab-encoding plasmid pDB88-8, and the mutant
derivatives of pDB88-8, were grown on BHI agar plates,
supplemented with ampicillin (100 mg/ml) at 37uC over night.
The FaeH- mutant strain contains a stop codon in faeH, whereas
the FaeI mutant strain contains a deletion in faeI, and the FaeJ
mutant strain contains a frameshift deletion in faeJ. The resulting
plasmids were named pDB88-141 (FaeH- mutant), pDB88-85
(FaeI- mutant) and pDB88-84 (FaeJ- mutant) [7]. After growing,
the bacteria were harvested by centrifugation and suspended in
PBS (phosphate-buffered saline, pH 7.3). The concentration of
bacteria in the suspensions were determined by measuring the
optical density at 660 nm (A660). An optical density of 1 equals 10
9
bacteria per milliliter, as determined by counting colony forming
units.
For metabolic labeling, the culture plates were supplemented
with 10 ml 35S-methionine (400 mCi; Amersham Pharmacia
Biotech). Bacteria were harvested, washed three times in PBS,
and resuspended in PBS containing 2% (w/v) bovine serum
albumin (MP Biomedicals, LLC, Illkirch, France) 0.1% (w/v)
NaN3 and 0.1% (w/v) Tween 20 (BSA/PBS/TWEEN) to a
bacterial density of 16108 colony forming units/ml. The specific
activity of bacterial suspensions was approximately 1 cpm per 100
bacteria.
Fimbrial preparations
The F4ab-, F4ac- and F4ad wild type fimbriae and F4ab mutant
fimbriae were purified as described by Van den Broeck et al. [48].
In short, the wild type F4 positive E. coli were grown in tryptone
soy broth (DIFCO Laboratories, Biotrading, Bierbeek, Belgium) at
37uC for 18 h while shaking at 85 rpm. The FaeH-, FaeI- and
FaeJ-mutant strains were grown in tryptone soy broth, supple-
mented with ampicillin (100 mg/ml) [7]. Bacteria were harvested
by centrifugation (3500 rpm, 30 min, 4uC), washed and suspended
in PBS. Subsequently, F4 fimbriae were isolated by homogenizing
the bacterial suspension using an Ultra Turrax (Janke & Kunkel,
IKA Labortechnik, Staufen, Germany) at 24,000 rpm for 15 min
keeping the suspension on ice. Next, the bacteria were pelleted by
centrifugation for 20 min at 10,0006g at 4uC, and the supernatant
was further purified by centrifugation for 40 min at 20,0006g at
4uC. The solubilized fimbriae were subsequently precipitated with
40% ammonium sulfate. After centrifugation, the pellet was
dissolved and dialyzed overnight against PBS. The protein
concentration of the isolated fimbriae was determined using the
bicinchoninic acid protein assay kit (Sigma-Aldrich, Bornem,
Belgium).
125I-labeling
Aliquots of 100 mg of protein were labeled with 125I, using
Na125I (100 mCi/ml; Amersham Pharmacia Biotech, Little
Chalfont, U.K.), according to the IODO-GEN protocol of the
manufacturer (Pierce, Rockford, IL), giving approximately
26103 cpm/mg protein.
Reference glycosphingolipids
Total acid and non-acid glycosphingolipid fractions were
isolated as described [49]. Individual glycosphingolipids were
isolated by repeated chromatography on silicic acid columns and
by HPLC, and identified by mass spectrometry [50] and 1H-NMR
spectroscopy [18]. Galactosylceramide (Galß1Cer) of bovine brain
with d18:1-h18:0-h24:0 ceramide was purchased from Sigma-
Aldrich, St. Louis, MO. Synthetic galabiaosylceramide (Gala4-
Galß1Cer) was a kind gift from late Dr. Go¨ran Magnusson, Lund
University, Sweden.
Thin-layer chromatography
Thin-layer chromatography was done on aluminum- or glass-
backed silica gel 60 high performance thin-layer chromatography
plates (Merck, Darmstadt, Germany). Glycosphingolipid mixtures
(10–80 mg) or pure glycosphingolipids (0.5–4 mg) were applied to
the plates, and if not otherwise stated, eluted with chloroform/
methanol/water (60:35:8, by volume). Chemical detection was
done with anisaldehyde [51].
Chromatogram binding assay
Binding of radiolabeled fimbriae and bacteria to glycosphingo-
lipids on thin-layer chromatograms was done as described
previously [37]. Dried chromatograms were dipped in diethy-
lether/n-hexane (1:5 v/v) containing 0.5% (w/v) polyisobutyl-
methacrylate for 1 min. To diminish background binding the
chromatograms were blocked with BSA/PBS/TWEEN for 2 h at
room temperature. Then the plates were incubated with 125I-
labeled fimbriae (1–56106 cpm/ml) or 35S-labeled bacteria (1–
56106 cpm/ml) diluted in BSA/PBS/TWEEN for another 2 h at
room temperature. After washing six times with PBS, and drying,
the thin-layer plates were autoradiographed for 12 h using XAR-5
x-ray films (Eastman Kodak, Rochester, NY).
Isolation of the F4 fimbriae binding slow-migrating
non-acid glycosphingolipids from chicken erythrocytes
Acid and non-acid glycosphingolipids were isolated from
chicken erythrocytes by standard methods [49]. Briefly, the
erythrocytes were lyophilized and then extracted in two steps in
a Soxhlet apparatus with chloroform and methanol (2:1 and 1:9,
by volume, respectively). The material obtained was subjected to
mild alkaline hydrolysis and dialysis, followed by separation on a
silicic acid column. Acid and non-acid glycosphingolipid fractions
were obtained by chromatography on a DEAE-cellulose column.
In order to separate the non-acid glycolipids from alkali-stable
phospholipids, this fraction was acetylated and separated on a
second silicic acid column, followed by deacetylation and dialysis.
Final purifications were done by chromatographies on DEAE-
cellulose and silicic acid columns.
Part of the non-acid glycosphingolipids (8.4 mg) were separated
on a 10 g Iatrobeads (Iatrobeads 6RS-8060; Iatron Laboratories,
Tokyo) column, eluted with chloroform/methanol/water 65:25:4
(by volume), 3260.5 ml, followed by chloroform/methanol/water
60:35:8 (by volume), 6660.5 ml, and finally chloroform/metha-
nol/water 40:40:12 (by volume), 15 ml. The fractions obtained
were tested for binding of F4ab and F4ad fimbriae using the
chromatogram binding assay. The F4-binding glycosphingolipid
migrating in the tetraglycosylceramide region was eluted in
fractions 65–71. Pooling of these fractions yielded 0.9 mg
(designated fraction C:tetra-I). The binding-active compound
migrating in the hexaglycosphingolipid region eluted in fractions
91–97, and after pooling of these fractions less than 0.1 mg was
obtained (designated fraction C:hexa). Proton NMR revealed that
fraction C:tetra-I was a mixture of four glycosphingolipids. This
fraction was therefore further separated on a 1 g Iatrobeads
column, eluted with chloroform/methanol/water 60:35:8 (by
volume), 1060.5 ml. Pooling of the F4-binding fractions gave
0.2 mg (designated fraction C:tetra-II).
Isolation of the F4ab/F4ac fimbriae binding non-acid
monoglycosylceramide from pig small intestinal mucosa
Acid and non-acid glycosphingolipids were isolated from mucosal
scrapings from the small intestine of an adult pig as described [49].
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Part of the non-acid glycosphingolipids (150 mg) was thereafter
separated by HPLC on a 2.1625 cm Kromasil 5 Silica column
(particle size 5 mm; Phenomenex, Torrence, CA), eluted with a
linear gradient of chloroform/methanol/water 90:10:1 to 60:35:8
(by volume) during 180 min with a flow rate of 2 ml/min. Aliquots
of each 2 ml fraction were analyzed by thin-layer chromatography,
and the fractions positive for anisaldehyde staining were further
tested for binding of F4ab fimbriae, using the chromatogram
binding assay. Glycosphingolipids migrating as monoglycosylcer-
amides were collected in tubes 41–72, and the F4ab fimbriae
binding compound was collected in tubes 62–65. Pooling of tubes
62–65 yielded 5.2 mg, and this fraction (designated fraction
P:mono) was used for structural characterization.
Isolation of the F4ab fimbriae binding non-acid
triglycosylceramide from pig small intestinal mucosa
The subfractions containing glycosphingolipids migrating as
diglycosylceramides and below, from the separation described
above, were pooled giving 26.4 mg. This material was separated
on an Iatrobeads (Iatrobeads 6RS-8060; Iatron Laboratories,
Tokyo) column (10 g), eluted with chloroform/methanol/water
65:25:4 (by volume), 465 ml, followed by 3661 ml, and finally
chloroform/methanol/water 60:35:8 (by volume), 1610 ml.
Compounds migrating in the triglycosylceramide region were
collected in fractions 14–29. The fractions were pooled into four
fractions according to thin-layer chromatographic resolution and
binding of F4ab fimbriae. The fraction designated fraction P:tri:I
(1.7 mg) had no F4ab binding activity. Fractions P:tri:II (0.9 mg)
and P:tri:III (1.0 mg) were recognized by the F4ab fimbriae, while
fractions P:tri:IV (0.3 mg) was non-binding.
Thin-layer chromatography - negative ion FAB mass
spectrometry
The acid glycosphingolipid fraction from newborn piglet small
intestinal mucosa (50 mg) was separated on aluminium-backed silica
gel 60 HPTLC plates using chloroform/methanol/water 60:35:8
(by volume) as solvent system. Several thin-layer chromatograms
were developed in parallel for bacterial binding, chemical staining
with anisaldehyde and thin-layer chromatography - negative ion
FAB mass spectrometry (TLC-FAB-MS), respectively [52]. Mass
spectrometry was performed with a ZAB-2F/HF mass spectrometer
(VG Analytical, Manchester, UK). For TLC-FAB-MS, a movable
FAB probe (VG Analytical) was used. The thin-layer plates with
separated glycosphingolipids were cut into 6 mm wide strips, and
after mounting on the probe, a layer of triethanolamine (Fluka,
Buchs, Switzerland) was applied using a soft roller. Negative ion
FAB mass spectra were produced by Xe atoms, 8 kV. Four scans
per mm of the thin-layer plate were recorded.
Negative ion FAB mass spectrometry
Negative ion FAB mass spectra of purified glycosphingolipids
were recorded on a JEOL SX-102A mass spectrometer (JEOL,
Tokyo, Japan). The ions were produced by 6 keV xenon atom
bombardment, using triethanolamine (Fluka, Buchs, Switzerland)
as matrix, and an accelerating voltage of 210 kV.
Endoglycoceramidase digestion and LC/MS
Endoglycoceramidase II from Rhodococcus spp. [53] (Takara Bio
Europe S.A., Gennevilliers, France) was used for hydrolysis of
glycosphingolipids. Briefly, 50 mg of the F4ab fimbriae binding
non-acid glycosphingolipid fractions from chicken erythrocytes
(fractions C:tetra and C:hexa) were resuspended in 100 ml 0.05 M
sodium acetate buffer, pH 5.0, containing 120 mg sodium cholate,
and sonicated briefly. Thereafter, 1 mU of endoglycoceramidase
II was added and the mixture was incubated at 37uC for 48 h. The
reaction was stopped by addition of chloroform/methanol/water
to the final proportions 8:4:3 (by volume). The oligosaccharide-
containing upper phase thus obtained was separated from
detergent on a Sep-Pak QMA cartridge (Waters, Milford, MA).
The eluant containing the oligosaccharides was dried under
nitrogen and under vacuum.
The glycosphingolipid-derived oligosaccharides were analyzed
by capillary-LC/MS and MS/MS as described [16]. In brief, the
oligosaccharides were separated on a column (20060.180 mm)
packed in-house with 5 mm porous graphite particles (Hypercarb,
Thermo Scientific), and eluted with an acetonitrile gradient (A:
8 mM ammonium bicarbonate; B: 100% acetonitrile). The
saccharides were analyzed in the negative ion mode on an LTQ
linear quadrupole ion trap mass spectrometer (Thermo Electron,
San Jose´, CA).
ESI/MS and ESI/MS/MS of native glycosphingolipids
The glycosphingolipids (dissolved in methanol) were analyzed
on an LTQ linear quadrupole ion trap mass spectrometer by static
nano-ESI/MS at 21.7 kV, using type F gold-coated needles
(Micromass/Waters, Milford, MA). Full-scan (m/z 380–2 000, 2
microscans, maximum 100 ms, target value of 30 000) was
performed, followed by data dependent MS2 scans (2 microscans,
maximum 100 ms, target value of 10 000) with normalized
collision energy of 30%, an isolation window of 3 m, an activation
q = 0.25, and an activation time of 30 ms.
Proton NMR spectroscopy
1H NMR spectra were acquired on a Varian 600 MHz
spectrometer at 30uC. Samples were dissolved in dimethyl
sulfoxide/D2O (98:2, by volume) after deuterium exchange.
Two-dimensional double quantum-filtered correlated spectrosco-
py (DQF-COSY) spectra were recorded by the standard pulse
sequence [54].
Supporting Information
Figure S1 Purified wild type and deletion mutant F4
fimbriae. The protein preparations were separated by SDS-
PAGE (12%), and stained by Coomassie Brilliant Blue R-250. The
lanes were; Lane 1, F4ab fimbriae with deletion of FaeH, 5 mg;
Lane 2, F4ab fimbriae with deletion of FaeI, 5 mg; Lane 3, F4ab
fimbriae with deletion of FaeJ, 5 mg; Lane 4, wild type F4ab
fimbriae, 5 mg; Lane 5, wild type F4ac fimbriae, 5 mg; Lane 6, wild
type F4ad fimbriae, 5 mg; Lane 7, molecular weight marker (kDa).
(TIFF)
Figure S2 ESI/MS/MS of the native fraction C:Tetra-II
from chicken erythrocytes. Above the spectrum is an
interpretation formula representing the molecular species with
t18:0-h16:0 ceramide.
(TIFF)
Figure S3 TLC-FAB-MS of the acid glycosphingolipids
from newborn piglet small intestinal mucosa. (A) Thin-
layer chromatogram stained with anisaldehyde. Acid glycosphin-
golipids (50 mg) of the epithelial cells of neonatal piglet small
intestine were separated on aluminum-backed HPTLC plates
using chloroform/methanol/water 60:35:8 (by volume) as solvent
system. (B) Autoradiogram obtained by binding of 125I-labeled
F4ab fimbriae to the acid glycosphingolipids of newborn piglet
small intestine. (C–E) Reconstructed curves of selected ions of
NeuGc-GM3 (C), sulfated dihexosylceramide (D) and sulfated
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monohexosylceramide (E), representing the successive detection of
different ceramide species. TLC-FAB-MS was performed as
described [52], using a ZAB-2F/HF mass spectrometer (VG
Analytical, Manchester, UK). Four scans per mm of the thin-layer
plate were recorded. The scanning of the thin-layer plate started at
the bottom (to the left in the figure) and was run approximately
60 mm upwards, giving in total about 250 scans. After scanning
approximately 40 mm of the thin-layer chromatogram, i.e. at the
level of the more slow-migrating F4ab-binding glycosphingolipid,
peaks appeared that corresponded to molecular ions of sulfated
dihexosylceramide. In scans 157–164, the peak at m/z 956,
corresponding to the species with d18:1-h16:0, was dominating,
and in scan 165 the species with t18:0-16:0 (m/z 958) dominated.
The following scans had peaks corresponding to d18:1-16:0 (m/z
940), d18:1-h22:0 (m/z 1040), and d18:1-h24:0 or t18:0-24:1 (m/z
1068) ceramides. At the level of the more fast-migrating F4ab-
binding compound (scans 168–211) molecular weight ions of
sulfated monohexosylceramide were obtained. Here, ions corre-
sponding to sulfated monohexosylceramide with d18:1-h16:0 (m/z
794), d18:1-16:0 (m/z 778), d18:1-h22:0 (m/z 878), d18:1-h24:0 or
t18:0-24:1 (m/z 906), and d18:1-24:0 (m/z 890) were found. Thus,
the more slow-migrating F4ab-binding glycosphingolipid was
tentatively identified as sulfated dihexosylceramide, while the
fast-migrating F4ab-binding binding glycosphingolipid was tenta-
tively identified as sulfated monohexosylceramide.
(TIFF)
Figure S4 Binding of deletion mutant F4ab fimbriae to
glycosphingolipids. Thin-layer chromatograms after chemical
detection by anisaldehyde (A and J), and autoradiograms obtained
by binding of 35S-labeled native F4ab fimbriae (B), F4ab fimbriae
with deletions of FaeH (C), FaeI (D) and FaeJ (E), and 35S-labeled
E. coli expressing native F4ab fimbriae (F), and F4ab fimbriae with
deletions of FaeH (G and K), FaeI (H and L) and FaeJ (I and M).
The glycosphingolipids were separated on aluminum-backed silica
gel plates, using chloroform/methanol/water (60:35:8, by volume)
as solvent system, and the binding assays were performed as
described under ‘‘Materials and Methods’’. Autoradiography
was for 12 h. The lanes on A-I were: Lane 1, Sulfatide (SO3-
3Galß1Cer) with t18:0-h24:0 ceramide, 4 mg; Lane 2, Galacto-
sylceramide (Galß1Cer) with d18:1-h18:0-h24:0 ceramide, 4 mg;
Lane 3, Lactosylceramide (Galß4Glcß1Cer) with t18:0-h16:0-
h24:0 ceramide, 4 mg; Lane 4, globotriaosylceramide (Gala4-
Galß4Glcß1Cer) with t18:0-22:0-24:0 ceramide, 4 mg; Lane 5,
globotetraosylceramide (GalNAcß3Gala4Galß4Glcß1Cer) with
t18:0-h16:0-h24:0 ceramide, 4 mg. The lanes on J-M were: Lane 6,
Lactosylceramide (Galß4Glcß1Cer) with t18:0-h16:0-h24:0 cer-
amide, 4 mg; Lane 7, globotriaosylceramide (Gala4Galß4Glcß1Cer)
with d18:1-16:0 and d18:1-24:0 ceramide, 4 mg; Lane 8, GalNA-
ca3GalNAcß3Galß4Glcß1Cer of chicken erythrocytes, 4 mg. The
glycosphingolipids visualized with anisaldehyde in (A) and (J) are
marked with Roman numbers, and the corresponding glycosphin-
golipid structures are are given to the right of the chromatograms.
(TIFF)
Table S1 Summary of results from binding of F4
fimbriae and F4-fimbriated Escherichia coli to glyco-
sphingolipids on thin-layer chromatograms.
(DOC)
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